Article Details
Retrieved on: 2020-12-02 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
He said regulators will review the same data provided for the emergency use by Pfizer and its partner <b>BioNTech</b> for the full approval. He did not say ...
Article found on: in.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here